{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:41:38Z","timestamp":1775094098715,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cancergen.2012.04.001","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T07:41:06Z","timestamp":1338968466000},"page":"193-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Molecular pathology and its diagnostic use in bone tumors"],"prefix":"10.1016","volume":"205","author":[{"given":"Karoly","family":"Szuhai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Cleton-Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pancras C.W.","family":"Hogendoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith V.M.G.","family":"Bov\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2012.04.001_bib1","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2012.04.001_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/gcc.20937","article-title":"Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data","volume":"51","author":"Wang","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/gcc.20886","article-title":"A\u00a0novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites","volume":"50","author":"Errani","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib4","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00000478-200105000-00019","article-title":"Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma","volume":"25","author":"Mendlick","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002409","article-title":"Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma","volume":"3","author":"Tanas","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cancergen.2012.04.001_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cancergen.2011.01.001","article-title":"Chromosome banding analysis of cells from fine-needle aspiration biopsy samples from soft tissue and bone tumors: is it clinically meaningful?","volume":"204","author":"Walther","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nprot.2006.41","article-title":"COBRA: combined binary ratio labeling of nucleic-acid probes for multi-color fluorescence in situ hybridization karyotyping","volume":"1","author":"Szuhai","year":"2006","journal-title":"Nature Protocols"},{"key":"10.1016\/j.cancergen.2012.04.001_bib8","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/humu.21423","article-title":"Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients","volume":"32","author":"Szuhai","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2012.04.001_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2350-12-85","article-title":"Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 Multiple Osteochondromas families","volume":"12","author":"Jennes","year":"2011","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-4-1","article-title":"Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples","volume":"4","author":"De Jong","year":"2011","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.cancergen.2012.04.001_bib11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/gcc.20817","article-title":"Small deletions but not methylation underlie CDKN2A\/p16 loss of expression in conventional osteosarcoma","volume":"49","author":"Mohseny","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000109614","article-title":"Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcoma","volume":"119","author":"Savola","year":"2007","journal-title":"Cytogenet Genome Res"},{"key":"10.1016\/j.cancergen.2012.04.001_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/path.2913","article-title":"IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours","volume":"224","author":"Amary","year":"2011","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib14","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ng.1004","article-title":"Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome","volume":"43","author":"Pansuriya","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib15","doi-asserted-by":"crossref","first-page":"e17791","DOI":"10.1371\/journal.pone.0017791","article-title":"Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR","volume":"6","author":"van Eijk","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cancergen.2012.04.001_bib16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2353\/jmoldx.2010.090237","article-title":"A\u00a0pyrosequencing-based assay for the rapid detection of IDH1 mutations in clinical samples","volume":"12","author":"Setty","year":"2010","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.cancergen.2012.04.001_bib17","article-title":"Genotyping by Allele-Specific Amplification (KASPar)","volume":"2007","author":"Cuppen","year":"2007","journal-title":"CSH Protoc"},{"key":"10.1016\/j.cancergen.2012.04.001_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cancergen.2011.07.008","article-title":"Promiscuous partnerships in Ewing\u2019s sarcoma","volume":"204","author":"Sankar","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib19","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.1998.16.4.1248","article-title":"EWS-FL11 fusion transcript structure is an independent determinant of prognosis in Ewing\u2019s sarcoma","volume":"16","author":"Alava","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib20","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1200\/JCO.2009.24.5845","article-title":"Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children\u2019s Oncology Group","volume":"28","author":"van Doorninck","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib21","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1200\/JCO.2009.23.3585","article-title":"Impact of EWS-ETS fusion type on disease progression in Ewing\u2019s sarcoma\/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial","volume":"28","author":"Le Deley","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.humpath.2011.04.023","article-title":"The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas","volume":"43","author":"Graham","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/gcc.20945","article-title":"High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas","volume":"51","author":"Italiano","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib24","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1158\/1078-0432.CCR-08-2184","article-title":"The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology","volume":"15","author":"Szuhai","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2012.04.001_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<265::AID-GCC12>3.0.CO;2-#","article-title":"Recurrent t(16;17)(q22;p13) in aneurysmal bone cysts","volume":"26","author":"Panoutsakopoulos","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib26","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1158\/0008-5472.CAN-03-2827","article-title":"USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst","volume":"64","author":"Oliveira","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.04.001_bib27","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/sj.onc.1208506","article-title":"Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes","volume":"24","author":"Oliveira","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2012.04.001_bib28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1200\/JCO.2005.04.4818","article-title":"Aneurysmal bone cyst: a neoplasm driven by upregulation of the USP6 oncogene","volume":"24","author":"Oliveira","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib29","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/MCB.23.6.2151-2161.2003","article-title":"The TRE17 oncogene encodes a component of a novel effector pathway for Rho GTPases Cdc42 and Rac1 and stimulates actin remodeling","volume":"23","author":"Masuda-Robens","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib30","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2010.116","article-title":"TRE17\/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB","volume":"29","author":"Ye","year":"2010","journal-title":"Oncogene"},{"issue":"47","key":"10.1016\/j.cancergen.2012.04.001_bib31","doi-asserted-by":"crossref","first-page":"37111","DOI":"10.1074\/jbc.M110.175133","article-title":"TRE17\/ubiquitin-specific protease 6 (USP6) oncogene translocated in aneurysmal bone cyst blocks osteoblastic maturation via an autocrine mechanism involving bone morphogenetic protein dysregulation","volume":"285","author":"Lau","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cancergen.2012.04.001_bib32","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)63432-3","article-title":"USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts","volume":"165","author":"Oliveira","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00256-007-0442-z","article-title":"Frequency of USP6 rearrangements in myositis ossificans, brown tumor, and cherubism: molecular cytogenetic evidence that a subset of \u201cmyositis ossificans-like lesions\u201d are the early phases in the formation of soft-tissue aneurysmal bone cyst","volume":"37","author":"Sukov","year":"2008","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib34","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/labinvest.2011.118","article-title":"Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion","volume":"91","author":"Erickson-Johnson","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.cancergen.2012.04.001_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-4608(00)00270-3","article-title":"Recurrent chromosome aberrations in fibrous dysplasia of the bone: a report of the CHAMP study group. CHromosomes And MorPhology","volume":"122","author":"Dal Cin","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2559.2007.02676.x","article-title":"A\u00a0sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone","volume":"50","author":"Idowu","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.cancergen.2012.04.001_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1359\/jbmr.2000.15.1.120","article-title":"Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone","volume":"15","author":"Bianco","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.cancergen.2012.04.001_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s004280000217","article-title":"Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone","volume":"437","author":"Okamoto","year":"2000","journal-title":"Virchows Arch"},{"key":"10.1016\/j.cancergen.2012.04.001_bib39","first-page":"1301","article-title":"Cellular\/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix","volume":"7","author":"Willems","year":"2009","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.cancergen.2012.04.001_bib40","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/modpathol.2009.32","article-title":"GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma","volume":"22","author":"Delaney","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/1096-8628(2000)9999:999<00::AID-AJMG1135>3.0.CO;2-A","article-title":"Mazabraud syndrome in two patients: clinical overlap with McCune-Albright syndrome","volume":"99","author":"Faivre","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s004280100453","article-title":"Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma","volume":"439","author":"Pollandt","year":"2001","journal-title":"Virchows Arch"},{"key":"10.1016\/j.cancergen.2012.04.001_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1525-1578(10)60618-6","article-title":"A\u00a0comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues","volume":"2","author":"Sakamoto","year":"2000","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.cancergen.2012.04.001_bib44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.tripleo.2009.12.016","article-title":"Analysis of GNAS mutations in cemento-ossifying fibromas and cemento-osseous dysplasias of the jaws","volume":"109","author":"Patel","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.cancergen.2012.04.001_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/modpathol.3800753","article-title":"Ossifying fibroma vs fibrous dysplasia of the jaw: molecular and immunological characterization","volume":"20","author":"Toyosawa","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib46","series-title":"World health organization classification of tumours. Pathology and genetics. Tumours of soft tissue and bone","first-page":"234","article-title":"Cartilage tumours","year":"2002"},{"key":"10.1016\/j.cancergen.2012.04.001_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ng1095-137","article-title":"Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1)","volume":"11","author":"Ahn","year":"1995","journal-title":"Nature Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0996-25","article-title":"The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes","volume":"14","author":"Stickens","year":"1996","journal-title":"Nature Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib49","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/hmg\/5.10.1547","article-title":"Positional cloning of a gene involved in hereditary multiple exostoses","volume":"5","author":"Wuyts","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/1097-0169(200102)48:2<149::AID-CM1005>3.0.CO;2-3","article-title":"Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes","volume":"48","author":"Bernard","year":"2001","journal-title":"Cell Motil Cytoskeleton"},{"key":"10.1016\/j.cancergen.2012.04.001_bib51","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1086\/302532","article-title":"EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas","volume":"65","author":"Bovee","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib52","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jnci\/djk067","article-title":"The role of EXT1 in non hereditary osteochondroma: identification of homozygous deletions","volume":"99","author":"Hameetman","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2012.04.001_bib53","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1073\/pnas.0910875107","article-title":"A\u00a0mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes","volume":"107","author":"Jones","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergen.2012.04.001_bib54","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/labinvest.2010.81","article-title":"Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma","volume":"90","author":"de Andrea","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.cancergen.2012.04.001_bib55","doi-asserted-by":"crossref","first-page":"e1000136","DOI":"10.1371\/journal.pgen.1000136","article-title":"Regulation of zebrafish skeletogenesis by ext2\/dackel and papst1\/pinscher","volume":"4","author":"Cl\u00e9ment","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib56","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1073\/pnas.0914431107","article-title":"EXTra hit for mouse osteochondroma","volume":"107","author":"Bovee","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergen.2012.04.001_bib57","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/onc.2011.311","article-title":"Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT","volume":"31","author":"de Andrea","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2012.04.001_bib58","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/ng.994","article-title":"Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2","volume":"43","author":"Amary","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib59","doi-asserted-by":"crossref","DOI":"10.1007\/s10014-012-0085-1","article-title":"Frequent IDH1\/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma","author":"Arai","year":"2012","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib60","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2559.2011.04010.x","article-title":"IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas","volume":"60","author":"Damato","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.cancergen.2012.04.001_bib61","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1111\/j.1582-4934.2008.00406.x","article-title":"Central chondrosarcoma progression is associated with pRb pathway alterations; CDK4 downregulation and p16 overexpression inhibit cell growth in\u00a0vitro","volume":"13","author":"Schrage","year":"2008","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.cancergen.2012.04.001_bib62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/path.1517","article-title":"Molecular analysis of the INK4A\/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression","volume":"202","author":"van Beerendonk","year":"2004","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib63","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/labinvest.3780202","article-title":"Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma","volume":"80","author":"Bovee","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.cancergen.2012.04.001_bib64","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/path.1723","article-title":"Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas","volume":"205","author":"Rozeman","year":"2005","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib65","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2353\/ajpath.2009.080623","article-title":"Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma","volume":"174","author":"Schrage","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib66","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2353\/ajpath.2006.050001","article-title":"Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation","volume":"168","author":"Tiet","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib67","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1158\/0008-5472.CAN-08-4801","article-title":"Kinome profiling of chondrosarcoma reveals Src-pathway activity and dasatinib as option for treatment","volume":"69","author":"Schrage","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.04.001_bib68","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/cncr.25632","article-title":"A\u00a0phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-alpha or -beta: An Italian Sarcoma Group study","volume":"117","author":"Grignani","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib69","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ccr.2009.05.013","article-title":"Gli2 and p53 cooperate to regulate IGFBP-3-mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors","volume":"16","author":"Ho","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2012.04.001_bib70","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2045-3329-1-5","article-title":"Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in\u00a0vitro and in\u00a0vivo","volume":"1","author":"Meijer","year":"2011","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.cancergen.2012.04.001_bib71","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1158\/1078-0432.CCR-05-1253","article-title":"Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma","volume":"11","author":"Cleton-Jansen","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2012.04.001_bib72","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2559.2010.03528.x","article-title":"Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours","volume":"56","author":"Boeuf","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.cancergen.2012.04.001_bib73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.1813","article-title":"cDNA expression profiling of central chondrosarcomas: Ollier disease resembles solitary tumors and alteration in genes coding for energy metabolism with increasing grade","volume":"207","author":"Rozeman","year":"2005","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib74","article-title":"Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in\u00a0vitro: BCL-2 family members cause chemoresistance","author":"van Oosterwijk","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/path.1987","article-title":"Brachyury and chordoma: the chondroid-chordoid dilemma resolved?","volume":"209","author":"Romeo","year":"2006","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/path.1969","article-title":"Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas","volume":"209","author":"Vujovic","year":"2006","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib77","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/43.4.7534785","article-title":"Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissues: A comparison of various antigen retrieval systems using microwave heating and proteolytic pre-treatments","volume":"43","author":"Hazelbag","year":"1995","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.cancergen.2012.04.001_bib78","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.bjc.6604130","article-title":"Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation","volume":"98","author":"Hallor","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib79","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ng.454","article-title":"T\u00a0(brachyury) gene duplication confers major susceptibility to familial chordoma","volume":"41","author":"Yang","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib80","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.2816","article-title":"Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study","volume":"223","author":"Presneau","year":"2011","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(03)00002-5","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms","volume":"143","author":"Sandberg","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.04.001_bib82","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2012.04.001_bib83","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/gcc.20120","article-title":"Gene amplifications in osteosarcoma-CGH microarray analysis","volume":"42","author":"Atiye","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib84","unstructured":"Lau C, Man TK, Visvanathan J, et\u00a0al. Molecular profiles of osteosarcoma that can predict response to chemotherapy. In: Proceedings of the Connective Tissue Oncology Society, 9th annual meeting. Montreal, Canada, 2004 Nov 11\u201313."},{"key":"10.1016\/j.cancergen.2012.04.001_bib85","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ijc.10709","article-title":"Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas","volume":"102","author":"Ozaki","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib86","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/gcc.10273","article-title":"High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays","volume":"38","author":"Squire","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib87","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/1098-2264(200007)28:3<329::AID-GCC11>3.0.CO;2-F","article-title":"Chromosomal regions involved in the pathogenesis of osteosarcomas","volume":"28","author":"Stock","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib88","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/gcc.20157","article-title":"An integrated mBAND and submegabase resolution tiling set (SMRT) CGH array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma","volume":"42","author":"Lim","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000151310","article-title":"Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH","volume":"122","author":"Selvarajah","year":"2008","journal-title":"Cytogenet Genome Res"},{"key":"10.1016\/j.cancergen.2012.04.001_bib90","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9440(10)65556-3","article-title":"CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations","volume":"153","author":"Nielsen","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib91","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<199::AID-IJC7>3.0.CO;2-4","article-title":"CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons","volume":"80","author":"Wei","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib92","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1200\/JCO.2005.04.074","article-title":"TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study","volume":"23","author":"Wunder","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib93","doi-asserted-by":"crossref","first-page":"11547","DOI":"10.1073\/pnas.1934852100","article-title":"The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability","volume":"100","author":"Overholtzer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergen.2012.04.001_bib94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/gcc.1207","article-title":"Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors","volume":"33","author":"Miller","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.04.001_bib95","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/path.2603","article-title":"Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2","volume":"219","author":"Mohseny","year":"2009","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib96","first-page":"1759","article-title":"Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma","volume":"63","author":"Ulaner","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.04.001_bib97","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1200\/JCO.2004.03.043","article-title":"Telomerase expression predicts unfavorable outcome in osteosarcoma","volume":"22","author":"Sanders","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.001_bib98","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3835(03)00189-7","article-title":"Telomerase activity in juxtacortical and conventional high-grade osteosarcomas: correlation with grade, proliferative activity and clinical response to chemotherapy","volume":"196","author":"Kido","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cancergen.2012.04.001_bib99","first-page":"2010","article-title":"Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage-activating agents","volume":"17","author":"Buddingh\u2019","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212001044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212001044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:37:49Z","timestamp":1761896269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776212001044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S2210776212001044"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.04.001","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular pathology and its diagnostic use in bone tumors","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}